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Background: Post-kala-azar dermal leishmaniasis is a well-known immunologic cutaneous reaction. There are few
case reports of ocular leishmaniasis. It is a sight-threatening condition that needs to be rapidly recognized and
treated to avoid permanent visual loss. Ocular leishmaniasis panuveitis can present with severe inflammation in
patients with highly active anti-retroviral therapy (HAART)-induced immune reconstitution syndrome.
Findings: A case of a 40-year-old man, human immunodeficiency virus (HIV) positive on HAART, with a presumed
diagnosis of ocular leishmaniasis, is presented. He had a past history of visceral leishmaniasis and was referred to the
uveitis service with rapidly worsening panuveitis and counting fingers vision in both eyes. On empirical anti-leishmania
therapy and systemic steroids, the visual acuity of the left eye improved to 6/9 but remained poor in the right eye.
Based on the medical history, improvement with therapy and the exclusion of other common infections, a presumed
diagnosis of ocular leishmaniasis-related panuveitis was made.
Conclusions: A major immune reaction against lingering parasites may play a key role in the pathogenesis of this
sight-threatening and rapidly progressive condition. Both the infection and the immune reaction should be treated.
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Introduction
Leishmaniasis is caused by Leishmania parasites transmit-
ted by sandflies to mammalian hosts. It is most commonly
found in rural impoverished areas of the Far and Middle
East; Central, Western and Eastern Europe; Africa; Asia;
and Central and South America [1]. There are about two
million new cases per year [1]. Three clinical syndromes
have been described: the cutaneous disease, the muco-
cutaneaous disease and the visceral disease, also named
kala-azar [2]. The cutaneous form is the commonest
form. Visceral leishmaniasis (VL) is the most severe
and may have a 75% to 95% mortality rate within the
first 2 years if left untreated.
Post-kala-azar dermal leishmaniasis is an immunologic
and cutaneous reaction in patients treated for visceral
leishmaniasis [3]. In human immunodeficiency virus
(HIV)-positive patients, the development of this cutaneous* Correspondence: peter.addison@moorfields.nhs.uk
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in any medium, provided the original work is pcondition has been reported as a manifestation of immune
reconstitution syndrome [4].
Ocular leishmaniasis has rarely been reported in the
literature [5-8]. The pathogenesis of ocular leishmaniasis
remains unclear. It is a sight-threatening condition, which
needs to be rapidly recognized and treated to prevent
permanent visual loss. Ocular leishmaniasis panuveitis
has been postulated to be a part of highly active anti-
retroviral therapy (HAART)-induced immune reconstitu-
tion syndrome in a co-infected HIV patient [8].
Case report
Written informed consent was obtained from the patient
for the publication of this report and any accompanying
images. Our patient was originally from Eritrea. He im-
migrated to the UK in 2005. He had been found to be
HIV-1 positive in 2008 when he presented with VL. He
then had good viral load suppression with anti-retroviral
therapy, but his maximum CD4 count was only 120
cells/mm3 (baseline 55 cells/mm3 at diagnosis); he had
not suffered opportunistic infections. However, his VL
recurred in June 2012 with a relapsing course requiring
five admissions despite appropriate prophylaxis withan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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entation of VL with fever, fatigue, anorexia, weight
loss, skin rash and splenomegaly. Amastigotes of Leish-
mania donovani were found on biopsy of split skin smear,
and he responded to prolonged treatment with liposomal
amphotericin B.
In April 2013, he presented with a recurrence of
maculo-papular rash, gradual onset blurred vision,
fatigue and headache less than a week after completing a
prolonged course of liposomal amphotericin B for a re-
lapse of leishmaniasis in February 2013. He was noted to
have optic disc oedema in both eyes (Figure 1), and hence,
neuroimaging and lumbar puncture were performed. No
abnormality was seen on magnetic resonance imaging
(MRI) scanning. L. donovani (LD) was detected by poly-
merase chain reaction (PCR) on cerebrospinal fluid ana-
lysis. Leishmania amastigotes were seen in (Figure 2) split
skin smear taken from his rash. He was treated with 28
days of intravenous sodium stibogluconate for disseminated
leishmaniasis with central nervous system involvement.
There was complete clinical recovery. His CD4 count
also reconstituted for the first time since diagnosis to
440 cells/mm3, without any change in his anti-retroviral
regimen.
In addition to anti-retroviral therapy, he was kept on
oral mitefosine, as leishmania prophylaxis. He remained
well until July 2013 when he re-presented with severe
headache and visual impairment. His visual acuity was
6/9 in both eyes. During this episode, acute bilateral
granulomatous anterior uveitis was noted with normal
posterior segment examination and normal optical coher-
ence tomography (OCT) (Figure 3). He was treated with
topical steroids. Unfortunately, within days, visual acuities
fell to counting fingers in both eyes. On examination, he
had severe bilateral granulomatous anterior uveitis with
hypopyon in the right eye, mutton fat keratic precipitates,
posterior synechiae and no view of the posterior segment
from either eye. He was started on hourly topical steroids
along with oral prednisone 60 mg once a day. B-scanFigure 1 Colour fundus photos of the disc. Showing presence of disc oultrasound examination in the right eye showed a tem-
poral supra-choroidal shallow elevation of 1.2 mm with
mild vitritis. All blood and radiological investigations were
normal or negative including Treponema serology and
QuantiFERON®-TB Gold (QFT-G, Cellestis Limited,
Carnegie, Victoria, Australia) for detecting TB-specific
T cells which were negative.
On topical and systemic steroids, there was resolution
of the hypopyon, and slit-lamp examination showed bi-
lateral corneal oedema with few Descemet's membrane
folds (Figure 4A). Follow-up B-scan showed bilateral
sessile temporal elevation of 1.7 and 1.9 mm in both
eyes (Figure 5A). As the patient was systemically unwell
with intractable headache, he was admitted under the
care of infectious disease specialists, and neuroimaging
with lumbar puncture was performed. No abnormal
findings were noted, and cerebrospinal fluid (CSF) analysis
did not show evidence of leishmanial DNA on PCR testing
or presence of amastigotes. Based on his past history of
recurrent VL, including central nervous system in-
volvement, his bilateral chronic granulomatous anterior
uveitis with exudative retinal detachment was attributed
to presumed ocular leishmaniasis, and he was started on
sodium stibogluconate treatment.
Microbiological analysis from vitreous biopsy was un-
remarkable and negative for microorganisms, including
Leishmania, toxoplasmosis, syphilis, tuberculosis, herpes
simplex virus (HSV), varicella-zoster virus (VZV) and
cytomegalovirus (CMV). As the patient was showing signs
of systemic and ocular improvement, he was kept on anti-
leishmania therapy plus oral and topical steroids.
On the last follow-up examination in November 2013,
the inflammation improved with the visual acuity improv-
ing to counting fingers and 6/24 in the right and left eyes,
respectively (Figure 4B). Anterior segment examination
revealed resolution of inflammation with presence of
posterior synechiae and posterior subcapsular cataract
in the right eye. He was maintained on sodium stibo-
gluconate and a tapering dose of oral corticosteroids,edema in the right (A) and left (B) eyes.
Figure 2 3D-OCT scan. Showing presence of normal macula and no evidence of fluid intraretinally or presence of any area of serous
retinal detachment.
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eye. The ultrasound of the posterior segment showed a
complete involution of the sessile nodular granulomatous
swelling in both eyes (Figure 5B). Unfortunately, after
the last follow-up, the patient expired due to his systemic
illness and concurrent infections.
Discussion
Visceral leishmaniasis (VL) may range from asymptom-
atic to a disseminated form. Patients with VL and HIV
co-infection usually have a CD4 count less than 200
cells/μl, may have involvement of atypical sites, like the
eye, and are prone to a relapsing VL course despite ap-
propriate treatment [9,10]. Leishmaniasis can present
with severe fulminant uveitis in patients with highly activeFigure 3 Giemsa stain of split skin smear. Showing presence of
leishmania amastigotes (red arrows) and kinetoplast (orange arrows)
on light microscopy.anti-retroviral therapy (HAART)-induced immune recon-
stitution syndrome [11]. HAART has resulted in decrease
in incidence of VL especially in the Mediterranean [12].
The recent studies have implicated the inadequacy of the
current treatment modality for HIV-associated visceral
leishmaniasis [13]. Lifelong prophylaxis is reported to be
necessary for HIV-associated visceral leishmaniasis [13].
Ocular leishmaniasis has been described in the litera-
ture as chronic blepharo-conjunctivitis and panuveitis
[5-8]. However, the pathogenesis of this condition is not
well established. El Hassan et al. published a short series
of six patients with presumed post-kala-azar ocular
leishmaniasis with two cases having severe granuloma-
tous panuveitis [5]. None of the cases were confirmed
microbiologically. All patients responded to systemic
anti-leishmania therapy plus topical steroids. Another
series published by Khalil et al. reported five cases of
ocular leishmaniasis panuveitis [6]. In this series, two
patients lost their sight permanently, but three were
successfully treated with oral and topical corticosteroids
along with anti-leishmania treatment.
A case of fulminant ocular leishmaniasis in an HIV-
positive patient was reported in 2004. This HIV-positive
patient on HAART for 2 years was previously diagnosed
and treated for VL. He also presented with a severe bilateral
granulomatous panuveitis with hypopyon. However, in this
case, leishmaniasis was confirmed by positive PCR analysis
in the aqueous humour and the cerebrospinal fluid [7].
Another similar HIV-positive case was also reported
in 2002. The patient had an initially low CD4 count
and lost his only eye despite anti-leishmania therapy.
The parasite was not identified until the enucleated
eyeball showed severe inflammation containing leish-
mania amastigotes. This situation was reported as a
Figure 4 Slit Lamp Photograph. Slit-lamp photograph of the left eye showing presence of chronic inflammation and Descemet membrane
folds (A) and resolution of inflammation and Descemet membrane folds after treatment (B).
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leishmaniasis [8].
Like other cases reported in the literature, our patient
with ocular leishmaniasis also has relapsed VL. Though
there was no further evidence of leishmanial infection, he
responded well to anti-leishmania therapy. The rationale
for giving concurrent oral corticosteroid therapy was
possible immune reconstitution response as our patient
was on HAART therapy. Well known in CMV retinitis, an
immune restitution phenomenon has also been described
in other conditions. Mycobacterium avium subclinical in-
fection has been associated with fever, leucocytosis and
lymphadenitis after initiation of HAART [14]. Meningitis
has also been reported in patients with latent cryptococcal
infection of the central nervous system after starting
HAART [15]. Biswas et al. have earlier reported a singleFigure 5 Ultrasound B-scan images of the right eye. Pre-treatment sho
(A) and resolution of the sessile swelling after treatment (B).case report of macular haemorrhage in both eyes of an im-
munocompetent patient who was having opportunistic in-
fection with leishmania [16]. In our case, the initial CD4
count was low (117 cells/μl) when the first and mild ocular
symptoms were reported. A few months later, subsequent
CD4 count increase to 330 cells/μl with concomitant severe
granulomatous panuveitis. Systemic corticosteroids were
necessary to control the inflammation. Hence, the possibil-
ity of immune reconstitution syndrome could not be ruled
out in our case, which is quite extensively reported in the
literature [17]. Biswas et al. have also reported a case of
immune reconstitution in an immune-compromised indi-
vidual after initiating protease inhibitors [17]. Based on the
patient response to treatment, empirical anti-leishmania
therapy and systemic corticosteroid may have contributed
to prevent ocular morbidity.wing presence of nodular sessile swelling in the temporal quadrant
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The diagnosis of ocular leishmaniasis-related panuveitis
is difficult and requires a high index of suspicion with
good knowledge of the past medical history. A bilateral
and severe granulomatous uveitis in an HIV-positive
patient with previous history of visceral leishmaniasis
should make the clinician suspicious of ocular leish-
maniasis. Prompt intervention with systemic therapy is
necessary to optimize the outcome. A major immune
reaction against lingering parasites might play a key role
in the pathogenesis of this rapidly sight-threatening condi-
tion. Both the infection and the immune reaction should
be kept in mind and targeted when treatment is planned.
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